Novel unimolecular tetra-agonist peptides targeting GLP-1, GIP, amylin, and calcitonin receptors with enhanced metabolic benefits in animal models of obesity
Injectable BPC-157: Higher Absorption and Targeted Repair Typical range: 2001,000 mcg per day Common dose: 500 mcg per day Method: Subcutaneous (SubQ) injection near the injury site or abdomen Cycle: 26 weeks depending on injury severity Injectable BPC-157 offers the highest bioavailability and fastest results, especially for tendon, ligament, and muscle injuries
Once reconstituted, the solution should be kept refrigerated and used within a short window to maintain compound integrity
Goel triple board-certified in Internal, Functional, and Aesthetic Medicine, Mount Sinai-trained, and an IFBB Masters Champion who lives the work
Frequently Asked Questions What is the primary difference in purity between GHK-Cu and GHK-Cu Cosmetic